-
Medical journals
- Career
Onkogeny RAS – prediktivní molekulární marker u kolorektálního karcinomu
Authors: J. Tomášek 1,2; J. Berkovcová 2,3
Authors‘ workplace: Klinika komplexní onkologické péče, Masarykův onkologický ústav, Brno 1; LF MU, Brno 2; 1. úsek diagnostické bioptické patologie, Masarykův onkologický ústav, Brno 3
Published in: Klin Onkol 2013; 26(5): 366-367
Category: Oncology Highlights
Sources
1. Adjei AA. Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 2001; 93(14): 1062–1074.
Labels
Paediatric clinical oncology Surgery Clinical oncology
Article was published inClinical Oncology
2013 Issue 5-
All articles in this issue
- Cyclins D in Regulation and Dysregulation of the Cell Cycle in Multiple Myeloma
- The Reasons of Changes in Revised Staging for Carcinoma of the Vulva
- Management of Infections in Palliative and Terminal Cancer Care
- Nephroblastoma – 30-Years Period of its Treatment in the University Hospital Motol, Prague
- Attainment of Complete Hematological Remission is Crucial for Extended Survival of AL Amyloidosis Patients with Cardiac Involvement
- The Clinical, Histopathological and Imaging Methods Characteristics of Non‑ Hodgkin Lymphomas in Patients with Brain Involvement
- Polyneuropathic Pain Therapy with a Patient Suffering from Generalized Castrate‑ Resistant Prostate Cancer – Clinical Case Report
- Chylous Ascites as a Serious Complication of the Neuroendocrine Tumor of Ileum – Case Report
- Patient with Atypical Neurocytoma – Case Report
- Onkogeny RAS – prediktivní molekulární marker u kolorektálního karcinomu
- Proliferation Activity in the Adult Rat Brain Following Exposure to Ionizing Radiation
- Clinical Oncology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Management of Infections in Palliative and Terminal Cancer Care
- Chylous Ascites as a Serious Complication of the Neuroendocrine Tumor of Ileum – Case Report
- Nephroblastoma – 30-Years Period of its Treatment in the University Hospital Motol, Prague
- The Reasons of Changes in Revised Staging for Carcinoma of the Vulva
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career